BioCryst
Trade BioCryst 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases.
BCRX Key Statistics
Stock Snapshot
The current BioCryst(BCRX) stock price is $6.70, with a market capitalization of 1.4B. The stock trades at a price-to-earnings (P/E) ratio of -140.80.
As of 2026-01-17, BioCryst(BCRX) stock has fluctuated between $6.58 and $7.17. The current price stands at $6.70, placing the stock +1.9% above today's low and -6.6% off the high.
The BioCryst(BCRX)'s current trading volume is 6.71M, compared to an average daily volume of 5.62M.
In the last year, BioCryst(BCRX) shares hit a 52-week high of $11.31 and a 52-week low of $6.00.
In the last year, BioCryst(BCRX) shares hit a 52-week high of $11.31 and a 52-week low of $6.00.
BCRX News
BioCryst Pharmaceuticals (BCRX) recently issued full year 2026 earnings guidance, telling investors it expects total revenue between US$635 million and US$660 m...
Serge Belanger, an analyst from Needham, maintained the Buy rating on BioCryst. The associated price target remains the same with $18.00. Claim 70% Off TipRanks...
Claim 70% Off TipRanks Premium BioCryst ( (BCRX) ) has issued an announcement. On January 12, 2026, BioCryst Pharmaceuticals reported that preliminary, unaudi...